FLUOROURACIL Side Effects

7028575-7 | Aortic Aneurysm, Dehydration, Diarrhoea
on Sep 30, 2010 Female patient from UNITED STATES , weighting 130.3 lb, was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm (What is aortic aneurysm?), dehydration, diarrhoea. Fluorouracil dosage: 18704 Mg. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (1180 Mg) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), CAMPTOSAR (1204 Mg) (View Camptosar Review and Camptosar Label ). Patient was hospitalized.

7027485-9 | Dehydration, Dyspnoea, Dyspnoea Exertional, Haemoglobin Decreased, Pancytopenia
Patient was taking Fluorouracil (View Usage). Patient had the following side effects: dehydration, dyspnoea, dyspnoea exertional, haemoglobin decreased, pancytopenia on Sep 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 165.3 lb, . Fluorouracil dosage: 2400 Mg. During the same period patient was treated with LEUCOVORIN CALCIUM (400 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (85 Mg) (View Eloxatin Review and Eloxatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NEXIUM (View Nexium Review and Nexium Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ). Patient was hospitalized.

7017825-9 | Blood Magnesium Decreased, Clostridium Test Positive, Culture Urine Positive, Disorientation, Escherichia Infection, Haemoglobin Decreased
Adverse event was reported on Sep 27, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: 1760 Mg) . Location: UNITED STATES , weighting 184.5 lb, After Fluorouracil was administered, patient had the following side effects: blood magnesium decreased, clostridium test positive, culture urine positive, disorientation, escherichia infection, haemoglobin decreased. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (1410 Mg) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), LEUCOVORIN CALCIUM (100 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (555 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

7016164-X | Multi-organ Failure
on Sep 14, 2010 Male patient from FRANCE , 75 years of age, was diagnosed with colon cancer and was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure. Fluorouracil dosage: 400 Mg/mm/15 Min Infusion.


7016102-X | Acute Interstitial Pneumonitis, Respiratory Failure
on Sep 14, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 69 years of age, was diagnosed with colon cancer and was treated with Fluorouracil (View Usage). Patient had the following side effects: acute interstitial pneumonitis, respiratory failure. Fluorouracil dosage: 400 Mg/mm Bolus Day 1. During the same period patient was treated with OXALIPLATIN (85 Mg/mm Day 1 Every Two Weeks) (View Oxaliplatin Review and Oxaliplatin Label ), CETUXIMAB (Infusion For Two Hours On Day 1) (View Cetuximab Review and Cetuximab Label ).

7006604-4 | Fatigue, Nausea, Pancytopenia
Patient was taking Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: fatigue, nausea (What is nausea?), pancytopenia on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 162.1 lb, . Fluorouracil dosage: 900 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (900 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), ELLENCE (137 Mg) (View Ellence Review and Ellence Label ). Patient was hospitalized.

7006603-2 | Nausea, Pancytopenia
Adverse event was reported on Sep 21, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: 900 Mg) . Location: UNITED STATES , weighting 162.1 lb, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), pancytopenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (900 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), ELLENCE (137 Mg) (View Ellence Review and Ellence Label ). Patient was hospitalized.

7006602-0 | Abdominal Pain, Endoscopy Upper Gastrointestinal Tract Abnormal, Haematemesis, Headache, Increased Upper Airway Secretion, Nausea, Pancreatitis
on Sep 21, 2010 Female patient from UNITED STATES , weighting 108.5 lb, was treated with Fluorouracil (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), endoscopy upper gastrointestinal tract abnormal, haematemesis, headache (What is headache?), increased upper airway secretion, nausea (What is nausea?), pancreatitis. Fluorouracil dosage: 4172 Mg. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (247 Mg) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), LEUCOVORIN CALCIUM (596 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (97 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

7005056-8 | Catheter Site Infection, Cellulitis
on Sep 20, 2010 Female patient from UNITED STATES , weighting 214.5 lb, was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: catheter site infection, cellulitis (What is cellulitis?). Fluorouracil dosage: 11085 Mg. During the same period patient was treated with ERBITUX (2968 Mg) (View Erbitux Review and Erbitux Label ), CAMPTOSAR (710 Mg) (View Camptosar Review and Camptosar Label ). Patient was hospitalized.

7004820-9 | Dehydration, Diarrhoea, Leukopenia, Multi-organ Failure, Odynophagia, Renal Failure, Septic Shock, Stomatitis, Thrombocytopenia
Patient was taking Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, leukopenia, multi-organ failure, odynophagia, renal failure, septic shock, stomatitis, thrombocytopenia on Aug 31, 2010 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with adenocarcinoma and. Fluorouracil dosage: (400 Mg/m2, As A 15 Minute Infusion) ; (2400 Mgm2, As A 48 Hours Infusion). During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6988393-2 | Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hyperbilirubinaemia, Hyperphagia
Adverse event was reported on Aug 16, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: 400 Mg/m2, Bolus, Intravenous; 2400 Mg/m2, Continuous 46 Hour Infusion, Intravenous) was diagnosed with rectal cancer metastatic and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hyperbilirubinaemia, hyperphagia. During the same period patient was treated with BRIVANIB ALANINATE (BRIVANIB ALANINAT) (200 Mg, 1 In 1 D, Oral) (View Brivanib Alaninate (brivanib Alaninat) Review and Brivanib Alaninate (brivanib Alaninat) Label ), LEUCOVORIN CALCIUM (400 Mg/m2, Once Every Two Weeks, Intravenous) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FLOMAX (MORNIFLUMATE) (View Flomax (morniflumate) Review and Flomax (morniflumate) Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), MEGACE (View Megace Review and Megace Label ), IMODIUM (View Imodium Review and Imodium Label ), LOMOTIL (LOMOTIL /00034001/) (View Lomotil (lomotil /00034001/) Review and Lomotil (lomotil /00034001/) Label ). Patient was hospitalized.

6983416-9 | Anaemia, Device Related Infection, Duodenal Ulcer, Gastrointestinal Haemorrhage, Serratia Test Positive
on Sep 14, 2010 Male patient from UNITED STATES , weighting 108.0 lb, was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: anaemia, device related infection, duodenal ulcer, gastrointestinal haemorrhage, serratia test positive. Fluorouracil dosage: 12112 Mg. During the same period patient was treated with ERBITUX (2160 Mg) (View Erbitux Review and Erbitux Label ), LEUCOVORIN CALCIUM (1720 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (368 Mg) (View Eloxatin Review and Eloxatin Label ), PERCOCET (View Percocet Review and Percocet Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6983409-1 | Acute Myelomonocytic Leukaemia, Dyspnoea
on Sep 14, 2010 Male patient from UNITED STATES , weighting 252.4 lb, was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myelomonocytic leukaemia, dyspnoea. Fluorouracil dosage: 82680 Mg. During the same period patient was treated with ELOXATIN (2102 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

6979608-5 | Abdominal Pain, Dehydration, Haematuria, Upper Gastrointestinal Haemorrhage
Patient was taking Fluorouracil (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, haematuria, upper gastrointestinal haemorrhage on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 286.6 lb, . Fluorouracil dosage: 3216 Mg. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (295 Mg) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), LEUCOVORIN CALCIUM (688 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6979597-3 | Asthenia, Dehydration, Diarrhoea, Hypokalaemia
Adverse event was reported on Sep 10, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: 18704 Mg) . Location: UNITED STATES , weighting 130.3 lb, After Fluorouracil was administered, patient had the following side effects: asthenia, dehydration, diarrhoea, hypokalaemia. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (1180 Mg) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), CAMPTOSAR (1204 Mg) (View Camptosar Review and Camptosar Label ). Patient was hospitalized.

6979275-0 | Cerebrovascular Accident
on Sep 03, 2010 Male patient from GERMANY , weighting 183.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Fluorouracil dosage: . During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ). Patient was hospitalized.

6974357-1 | Abdominal Pain Upper, Abdominal Tenderness, Decreased Appetite, Dehydration, Diarrhoea, Fatigue, Pancytopenia, Pyrexia, Renal Failure Acute
on Aug 26, 2010 Male patient from UNITED KINGDOM , 35 years of age, was diagnosed with gastric cancer and was treated with Fluorouracil (View Usage). Patient had the following side effects: abdominal pain upper, abdominal tenderness, decreased appetite, dehydration, diarrhoea, fatigue, pancytopenia, pyrexia, renal failure acute. Fluorouracil dosage: Unk. During the same period patient was treated with DIPYRIDAMOLE (WATSON LABORATORIES) (Unk) (View Dipyridamole (watson Laboratories) Review and Dipyridamole (watson Laboratories) Label ), GRANISETRON HYDROCHLORIDE (WATSON LABORATORIES) (Unk) (View Granisetron Hydrochloride (watson Laboratories) Review and Granisetron Hydrochloride (watson Laboratories) Label ), NAPROXEN SODIUM (WATSON LABORATORIES) (Unk) (View Naproxen Sodium (watson Laboratories) Review and Naproxen Sodium (watson Laboratories) Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), CISPLATIN (60 Mg, Unk) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6971525-X | Acute Respiratory Distress Syndrome, Cough, Dyspnoea, Endotracheal Intubation, Fungal Infection, Hypoxia, Intermittent Positive Pressure Breathing, Interstitial Lung Disease, Mechanical Ventilation
Patient was taking Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: acute respiratory distress syndrome, cough, dyspnoea, endotracheal intubation, fungal infection (What is fungal infection?), hypoxia, intermittent positive pressure breathing, interstitial lung disease, mechanical ventilation on Aug 27, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 69 years of age, was diagnosed with colorectal cancer metastatic and. Fluorouracil dosage: 400 Mg/m2 Bolus Infusion On Day 1, Every 2 Weeks. During the same period patient was treated with OXALIPLATIN (85 Mg/m2 On Day 1, Every 2 Weeks) (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (NGX) (200 Mg/m2 Over 2 Hours On Days 1 And 2, Every 2 Weeks) (View Leucovorin Calcium (ngx) Review and Leucovorin Calcium (ngx) Label ), CETUXIMAB (For 2 H, On Day 1) (View Cetuximab Review and Cetuximab Label ).

6969415-1 | Haematocrit Decreased, Haemoglobin Decreased, Haemolysis, Red Blood Cell Count Decreased, Shock, Somnolence
Adverse event was reported on Aug 17, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: (fortnightly Basis)) was diagnosed with bile duct cancer and. Location: GERMANY , 57 years of age, Patient experienced the following unwanted or unexpected effects: haematocrit decreased, haemoglobin decreased, haemolysis, red blood cell count decreased, shock, somnolence. During the same period patient was treated with OXALIPLATIN (OXALIPLATIN) (OXALIPLATIN) (View Oxaliplatin (oxaliplatin) (oxaliplatin) Review and Oxaliplatin (oxaliplatin) (oxaliplatin) Label ), FOLINIC ACID (FOLINIC ACID) (FOLINIC ACID) (View Folinic Acid (folinic Acid) (folinic Acid) Review and Folinic Acid (folinic Acid) (folinic Acid) Label ), METAMIZOLE (METAMIZOLE) (METAMIZOLE) (View Metamizole (metamizole) (metamizole) Review and Metamizole (metamizole) (metamizole) Label ).

6968692-0 | Interstitial Lung Disease
on Aug 30, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 69 years of age, was diagnosed with colorectal cancer metastatic and was treated with Fluorouracil (View Usage). Patient had the following side effects: interstitial lung disease. Fluorouracil dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

6967262-8 | Decreased Appetite, Diarrhoea, Hypokalaemia, Leukopenia, Nausea
on Jun 23, 2010 Female patient from UNITED KINGDOM , 56 years of age, was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: decreased appetite, diarrhoea, hypokalaemia, leukopenia, nausea (What is nausea?). Fluorouracil dosage: 3300.00 Mg Intravenous (not Otherwise Specified). During the same period patient was treated with IRINOTECAN HCL (300.00 Mg Intravenous (not Otherwise Specified)) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), LEUCOVORIN(LEUCOVORIN) (View Leucovorin(leucovorin) Review and Leucovorin(leucovorin) Label ), LIMICAN(LIMICAN) (View Limican(limican) Review and Limican(limican) Label ), DECADRON(DECADRON) (View Decadron(decadron) Review and Decadron(decadron) Label ). Patient was hospitalized.

6967237-9 | Angina Pectoris
Patient was taking Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris on Jun 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, . Fluorouracil dosage: 3557.00 Mg Intravenous (not Otherwise Specified). During the same period patient was treated with IRINOTECAN HCL (142.40 Mg Intravenous (not Otherwise Specified)) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AVASTIN (350.00 Mg) (View Avastin Review and Avastin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM LEVOFOLINATE(CALCIUM LEVOFOLINATE) (View Calcium Levofolinate(calcium Levofolinate) Review and Calcium Levofolinate(calcium Levofolinate) Label ). Patient was hospitalized.

6963796-0 | Ileus Paralytic
Adverse event was reported on Aug 27, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: Unk) was diagnosed with colon cancer and. Location: ITALY , 60 years of age, Patient had the following side effects: ileus paralytic.

6962199-2 | Abdominal Pain, Anaemia, Cyanosis, Dilatation Ventricular, Dysuria, Gallop Rhythm Present, Gastritis, Hypoalbuminaemia, Hypotension
on Sep 01, 2010 Female patient from UNITED STATES , weighting 55.56 lb, was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, cyanosis, dilatation ventricular, dysuria, gallop rhythm present, gastritis, hypoalbuminaemia, hypotension. Fluorouracil dosage: 500 Mg. During the same period patient was treated with CISPLATIN (86 Mg) (View Cisplatin Review and Cisplatin Label ), DOXORUBICIN HYDROCHLORIDE (50 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE SULFATE (1.2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6961417-4 | Arthralgia, Contusion, Decreased Appetite, Diarrhoea, Ear, Nose And Throat Examination Abnormal, Fatigue, Gait Disturbance, Hair Disorder
on Aug 23, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with precancerous mucosal lesion and was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, contusion, decreased appetite, diarrhoea, ear, nose and throat examination abnormal, fatigue, gait disturbance, hair disorder. Fluorouracil dosage: .

6959379-9 | Anaemia, Arthritis Bacterial, Bacterial Sepsis, Blood Creatinine Increased, Depression, Diarrhoea, Hypertension, Hyponatraemia
Patient was taking Fluorouracil (View Usage). Patient had the following side effects: anaemia, arthritis bacterial, bacterial sepsis, blood creatinine increased, depression (What is depression?), diarrhoea, hypertension, hyponatraemia on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 247.5 lb, . Fluorouracil dosage: 9000 Mg. During the same period patient was treated with ELOXATIN (200 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

6959083-7 | Cardiac Arrest, Cardiac Infection, Pneumonia, Respiratory Failure
Adverse event was reported on Aug 23, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: NETHERLANDS , weighting 185.2 lb, After Fluorouracil was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiac infection, pneumonia (What is pneumonia?), respiratory failure. During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ). Patient was hospitalized.

6941314-0 | Cholecystitis Acute, Enterobacter Sepsis
on Aug 19, 2010 Male patient from UNITED STATES , 57 years of age, weighting 135.5 lb, was diagnosed with metastatic neoplasm and was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis acute, enterobacter sepsis. Fluorouracil dosage: . During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6940534-9 | Hypertension
on Aug 16, 2010 Male patient from FRANCE , 54 years of age, was diagnosed with colorectal cancer metastatic and was treated with Fluorouracil (View Usage). Patient had the following side effects: hypertension. Fluorouracil dosage: 800 Mg. During the same period patient was treated with IRINOTECAN HCL (520 Mg, 1x/day) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FOLINIC ACID (800 Mg, 1x/day) (View Folinic Acid Review and Folinic Acid Label ), AVASTIN (425 Mg, 1x/day) (View Avastin Review and Avastin Label ). Patient was hospitalized.

6938104-1 | Anaemia, Klebsiella Sepsis
Patient was taking Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: anaemia, klebsiella sepsis on Aug 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Fluorouracil dosage: Intravenous Drip. During the same period patient was treated with OXALIPLATIN (Intravenous Drip) (View Oxaliplatin Review and Oxaliplatin Label ), ATORVASTATIN (ATORVASTATIN) (ATORVASTATIN) (View Atorvastatin (atorvastatin) (atorvastatin) Review and Atorvastatin (atorvastatin) (atorvastatin) Label ), CINCHOCAINE HYDROCHLORIDE (CINCHOCAINE HYDROCHLORIDE) (CINCHOCAINE HYD (View Cinchocaine Hydrochloride (cinchocaine Hydrochloride) (cinchocaine Hyd Review and Cinchocaine Hydrochloride (cinchocaine Hydrochloride) (cinchocaine Hyd Label ), DOMPERIDONE (DOMPERIDONE) (DOMPERIDONE) (View Domperidone (domperidone) (domperidone) Review and Domperidone (domperidone) (domperidone) Label ), FELODIPINE (FELODIPINE) (FELODIPINE) (View Felodipine (felodipine) (felodipine) Review and Felodipine (felodipine) (felodipine) Label ), HYDROCORTISONE (HYDROCORTISONE) (HYDROCORTISONE) (View Hydrocortisone (hydrocortisone) (hydrocortisone) Review and Hydrocortisone (hydrocortisone) (hydrocortisone) Label ). Patient was hospitalized.

6937320-2 | Cardiogenic Shock, Chest Pain, Hypokinesia, Left Ventricular Dysfunction
Adverse event was reported on Aug 11, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: Unk) was diagnosed with neoplasm progression and. Location: ALBANIA , 51 years of age, Patient experienced the following unwanted or unexpected effects: cardiogenic shock, chest pain (What is chest pain?), hypokinesia, left ventricular dysfunction. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (Unk) (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), LEUCOVORIN CALCIUM (Unk) (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6936374-7 | Anxiety, Cyanosis, Dyspnoea, Pulmonary Oedema
on Aug 16, 2010 Male patient from ROMANIA , 70 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Fluorouracil (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cyanosis, dyspnoea, pulmonary oedema. Fluorouracil dosage: Unk. During the same period patient was treated with FOLINIC ACID (NGX) (Unk) (View Folinic Acid (ngx) Review and Folinic Acid (ngx) Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), MONOCLONAL ANTIBODIES (View Monoclonal Antibodies Review and Monoclonal Antibodies Label ), LOPERAMIDE (2 Mg, Unk) (View Loperamide Review and Loperamide Label ).

6935898-6 | Arteriospasm Coronary, Cardiogenic Shock, Cardiotoxicity, Chest Pain, Hypokinesia, Left Ventricular Dysfunction, Troponin I Increased
on Aug 04, 2010 Male patient from FRANCE , 51 years of age, was diagnosed with lung neoplasm malignant and was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: arteriospasm coronary, cardiogenic shock, cardiotoxicity, chest pain (What is chest pain?), hypokinesia, left ventricular dysfunction, troponin i increased. Fluorouracil dosage: 46h Infusion, Intravenous (not Otherwise Specified). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), TARCEVA (ERLOTINIB) (View Tarceva (erlotinib) Review and Tarceva (erlotinib) Label ), ALIMTA (View Alimta Review and Alimta Label ), LEUCOVORINE (CALCIUM FOLINATE) (View Leucovorine (calcium Folinate) Review and Leucovorine (calcium Folinate) Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6934506-8 | Ileus Paralytic
Patient was taking Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: ileus paralytic on Aug 10, 2010 from ITALY Additional patient health information: Male patient , 60 years of age, was diagnosed with colon cancer and. Fluorouracil dosage: Unk.

6931025-X | Abdominal Pain, Diarrhoea
Adverse event was reported on Aug 17, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: 4076) . Location: UNITED STATES , weighting 163.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea. During the same period patient was treated with ERBITUX (455 Mg) (View Erbitux Review and Erbitux Label ), CAMPTOSAR (273 Mg) (View Camptosar Review and Camptosar Label ), LEUCOVORIN CALCIUM (728 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6924255-4 | Dehydration, Dizziness, Dyspnoea Exertional, Fatigue, Pancytopenia
on Aug 11, 2010 Female patient from UNITED STATES , weighting 165.3 lb, was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: dehydration, dizziness (What is dizziness?), dyspnoea exertional, fatigue, pancytopenia. Fluorouracil dosage: 2400 Mg. During the same period patient was treated with LEUCOVORIN CALCIUM (400 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (85 Mg) (View Eloxatin Review and Eloxatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NEXIUM (View Nexium Review and Nexium Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ). Patient was hospitalized.

6922999-1 | Antibody Test Positive, Haemolysis
on Aug 02, 2010 Female patient from ALBANIA , 57 years of age, was diagnosed with bile duct cancer and was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: antibody test positive, haemolysis. Fluorouracil dosage: Every 2 Weeks. During the same period patient was treated with OXALIPLATIN (Every 2 Weeks) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (Every 2 Weeks) (View Folinic Acid Review and Folinic Acid Label ).

6909355-7 | Erythema Multiforme
Patient was taking Fluorouracil (View Usage). Patient had the following side effects: erythema multiforme on Jul 26, 2010 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with anal cancer (What is anal cancer?) and. Fluorouracil dosage: 1000 Mg/m2, Daily. During the same period patient was treated with MITOMYCIN (10 Mg/m2, Daily) (View Mitomycin Review and Mitomycin Label ).

6909204-7 | Eye Discharge, Retinal Disorder, Vision Blurred
Adverse event was reported on Jul 30, 2010 by a Male patient taking Fluorouracil (View Usage) (Dosage: ) was diagnosed with precancerous skin lesion and. Location: UNITED STATES , 45 years of age, weighting 174.2 lb, After Fluorouracil was administered, patient had the following side effects: eye discharge, retinal disorder (What is retinal disorder?), vision blurred. During the same period patient was treated with MULTIPLE VITAMINS (View Multiple Vitamins Review and Multiple Vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ).

6905913-4 | Chest Pain, Deep Vein Thrombosis, Hyperhidrosis, Pulmonary Embolism
on Aug 03, 2010 Male patient from UNITED STATES , weighting 255.0 lb, was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), hyperhidrosis, pulmonary embolism (What is pulmonary embolism?). Fluorouracil dosage: 6552 Mg. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGF) (578) (View Bevacizumab (rhumab Vegf) Review and Bevacizumab (rhumab Vegf) Label ), LEUCOVORIN CALCIUM (936 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (199 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

6900533-X | Mucosal Inflammation
on Jul 27, 2010 Male patient from GERMANY , 68 years of age, weighting 167.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Fluorouracil (View Usage). Patient had the following side effects: mucosal inflammation. Fluorouracil dosage: . During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6885308-2 | Arthralgia, Gait Disturbance, Joint Swelling, Musculoskeletal Stiffness, Oedema Peripheral, Pain In Extremity
Patient was taking Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: arthralgia, gait disturbance, joint swelling, musculoskeletal stiffness, oedema peripheral, pain in extremity on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with precancerous skin lesion and. Fluorouracil dosage: Sm. Amt Twice Day Skin.

6882461-1 | Dehydration, Dizziness, Pancytopenia, White Blood Cell Count Increased
Adverse event was reported on Jul 28, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: 2400 Mg) . Location: UNITED STATES , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: dehydration, dizziness (What is dizziness?), pancytopenia, white blood cell count increased. During the same period patient was treated with LEUCOVORIN CALCIUM (400 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (85 Mg) (View Eloxatin Review and Eloxatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NEXIUM (View Nexium Review and Nexium Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

6879457-2 | Arteriospasm Coronary, Bradyarrhythmia, Cardiotoxicity
on Jul 16, 2010 Male patient from AUSTRALIA , 70 years of age, was diagnosed with colon cancer and was treated with Fluorouracil (View Usage). Patient had the following side effects: arteriospasm coronary, bradyarrhythmia, cardiotoxicity. Fluorouracil dosage: Unk. During the same period patient was treated with OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (Unk) (View Folinic Acid Review and Folinic Acid Label ).

6879455-9 | Myocardial Infarction
on Jul 16, 2010 Male patient from AUSTRALIA , 66 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: myocardial infarction. Fluorouracil dosage: 1 G/ Mm. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6879453-5 | Atrioventricular Block
Patient was taking Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block on Jul 16, 2010 from AUSTRALIA Additional patient health information: Male patient , 64 years of age, was diagnosed with oesophageal adenocarcinoma and. Fluorouracil dosage: Unk.

6879451-1 | Stress Cardiomyopathy
Adverse event was reported on Jul 16, 2010 by a Female patient taking Fluorouracil (View Usage) (Dosage: Unk) was diagnosed with colon cancer and. Location: AUSTRALIA , 81 years of age, Patient had the following side effects: stress cardiomyopathy. During the same period patient was treated with CAPECITABINE (Unk) (View Capecitabine Review and Capecitabine Label ), FOLINIC ACID (Unk) (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6878960-9 | Cardiomyopathy
on Jul 16, 2010 Female patient from AUSTRALIA , 58 years of age, was diagnosed with colon cancer and was treated with Fluorouracil (View Usage). After Fluorouracil was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Fluorouracil dosage: 400 Mg/m2, Every 2 Weeks. During the same period patient was treated with OXALIPLATIN (85 Mg/m2, Daily (day 1)) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (20 Mg/m2, Daily (day 1)) (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6874517-4 | Duodenitis, Gallbladder Disorder, Ileitis
on Jul 23, 2010 Male patient from UNITED STATES , weighting 152.8 lb, was treated with Fluorouracil (View Usage). Patient experienced the following unwanted or unexpected effects: duodenitis, gallbladder disorder, ileitis. Fluorouracil dosage: 10304 Mg. During the same period patient was treated with BEVACIZUMAB (RHUMAB VEGG) (704 Mg) (View Bevacizumab (rhumab Vegg) Review and Bevacizumab (rhumab Vegg) Label ), LEUCOVORIN CALCIUM (1472 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ELOXATIN (312 Mg) (View Eloxatin Review and Eloxatin Label ). Patient was hospitalized.

6869086-9 | Cellulitis, Device Related Infection
Patient was taking Fluorouracil (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), device related infection on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 128.5 lb, . Fluorouracil dosage: 4704 Mg. During the same period patient was treated with ELOXATIN (143 Mg) (View Eloxatin Review and Eloxatin Label ), LEUCOVORIN CALCIUM (672 Mg) (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.